Researchers at Sanofi have unveiled a groundbreaking gene editing technology, cas-CLOVER, which shows exceptional promise in enhancing recombinant protein production in Chinese hamster ovary (CHO) cells. This innovative approach offers a compelling alternative to the widely used CRISPR-Cas9 system, potentially leading to more efficient and precise genetic modifications.
Exploring Cas-CLOVER Technology
The cas-CLOVER system is based on a deactivated Cas9 protein linked to Clostridium Clo051, which allows for targeted gene editing while minimizing off-target effects. Tiffany McLamarrah, PhD, a principal scientist at Sanofi, emphasizes the need for a gene editing technology that not only maintains the ease and efficiency of CRISPR-Cas9 but also provides broader freedom to operate. Initial studies have demonstrated an impressive editing efficiency of around 90% in HEK-293 cells, and research is now expanding to CHO cells.
Evaluating Gene Editing Efficiency
In a recent study led by McLamarrah, the efficiency of cas-CLOVER was assessed through the knockout of the glutamine synthetase locus in CHO cells. The research team generated over 100 clones from 30 different serum-free suspension-adapted CHO-K1 host cell lines. Remarkably, 98 of these clones exhibited complete knockout of the target gene within a rapid timeframe of just six weeks, comparable to the speed of CRISPR-Cas9 knockouts.
Enhancing Monoclonal Antibody Production
The next phase involved selecting glutamine synthetase knockout clones as production vehicles for monoclonal antibodies. The results were striking, with titers increasing by as much as 14.4-fold compared to their wild-type parental counterparts. This significant increase underscores the variability among CHO cells and the vector systems employed in producing these pools, highlighting the potential for optimized protein production.
The Role of Glutamine Synthetase
While achieving a knockout of glutamine synthetase was crucial, the researchers discovered that merely reducing its expression was insufficient for maximizing productivity. They also needed to attenuate the exogenously expressed glutamine synthetase to obtain a higher titer of knockouts when compared to wild-type cells. This comprehensive strategy illustrates the complexity of optimizing gene editing for enhanced protein production.
Understanding Indel Characteristics
An intriguing aspect of the cas-CLOVER system is the nature of the indels it generates. The sizes of these indels are typically larger than those produced by CRISPR-Cas9, ranging from a gain of 13 base pairs to a loss of 128 base pairs. The most frequent deletions observed were -12 bp and -26 bp, which occurred at rates of 3.7% and 3.3%, respectively. Notably, 92.7% of the indels began within a 73 bp range that included the two sgRNAs and their corresponding protospacer adjacent motifs, indicating a strong trend in the cleavage patterns.
Advantages of Staggered Cuts
The staggered cuts produced by cas-CLOVER may facilitate larger indels, which can enhance both the efficiency of knock-ins and the simplicity of generating knock-outs. McLamarrah explains that deleting 20 to 30 base pairs can effectively remove specific amino acids essential for the function of certain genes, often avoiding the need for frameshifts. This targeted approach ensures complete knockout of the protein while minimizing the risk of future rearrangements that could restore its function.
Confirmation of Gene Knockouts
To validate their findings, the research team employed high-resolution next-generation sequencing (NGS) and fragment analysis capillary electrophoresis (FA-CE), confirming that 97% of the indel sizes fell within a 1 bp margin of error. Additionally, behavioral confirmation of gene knockout was achieved by culturing the GSKO clones in media devoid of glutamine supplements. The clones exhibited glutamine auxotrophic behavior, showing a significant decline in viability over time, while cells supplemented with glutamine maintained viability throughout the study.
The Importance of Host Cell Line Selection
The study’s outcomes reveal that productivity is significantly influenced by the choice of CHO-K1 host cell lines. This emphasizes the need for comprehensive screening of host cell lines to identify the most effective candidates for specific gene editing applications. As research progresses, McLamarrah highlights the necessity of determining off-target effects within CHO cells and exploring further knock-ins to optimize production capabilities.
Future Directions in Gene Editing
As the cas-CLOVER technology matures, it holds promise for transforming the landscape of gene editing in biopharmaceutical production. The ability to achieve high editing efficiencies with reduced off-target effects positions this system as a leading candidate for future applications in cell line engineering.
In conclusion, cas-CLOVER represents a significant advancement in gene editing technology, particularly for enhancing protein production in CHO cells. Its unique capabilities could pave the way for more efficient therapeutic development, potentially revolutionizing the production of monoclonal antibodies and other biologics.
- Cas-CLOVER offers a promising alternative to CRISPR-Cas9 for gene editing in CHO cells.
- The system has demonstrated high editing efficiency and potential for reduced off-target effects.
- Significant productivity increases were observed in monoclonal antibody production through targeted gene knockout.
- The choice of host cell lines is crucial for optimizing protein production.
- Future research will focus on exploring off-target effects and expanding knock-in applications.
Read more → www.genengnews.com